The Translational Paradox of Cancer Nanomedicine: Biological, Pharmacokinetic, and Manufacturing Barriers to Clinical Success.

Jankowska J, Szeleszczuk Ł, Pisklak DM

Open source

DOI
10.3390/biology15171550
Published
2026 Sep 4
Container
Biology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biology15171550,
  title = {The Translational Paradox of Cancer Nanomedicine: Biological, Pharmacokinetic, and Manufacturing Barriers to Clinical Success.},
  author = {Jankowska J and Szeleszczuk Ł and Pisklak DM},
  year = {2026},
  journal = {Biology},
  doi = {10.3390/biology15171550},
  url = {https://doi.org/10.3390/biology15171550}
}

RIS

TY  - JOUR
TI  - The Translational Paradox of Cancer Nanomedicine: Biological, Pharmacokinetic, and Manufacturing Barriers to Clinical Success.
AU  - Jankowska J
AU  - Szeleszczuk Ł
AU  - Pisklak DM
PY  - 2026
JO  - Biology
DO  - 10.3390/biology15171550
UR  - https://doi.org/10.3390/biology15171550
ER  - 

APA

J, J., Ł, S., & DM, P. (2026). The Translational Paradox of Cancer Nanomedicine: Biological, Pharmacokinetic, and Manufacturing Barriers to Clinical Success.. Biology. https://doi.org/10.3390/biology15171550

Source records